Skip to Content

Sodium Zirconium Cyclosilicate use while Breastfeeding

Drugs containing Sodium Zirconium Cyclosilicate: Lokelma

Medically reviewed by Drugs.com. Last updated on Jul 8, 2021.

Sodium Zirconium Cyclosilicate Levels and Effects while Breastfeeding

Summary of Use during Lactation

Because sodium zirconium cyclosilicate is not orally absorbed it is unlikely to reach the breastmilk or adversely affect the breastfed infant. No special precautions are required.

Drug Levels

Maternal Levels. Relevant published information was not found as of the revision date.

Infant Levels. Relevant published information was not found as of the revision date.

Effects in Breastfed Infants

Relevant published information was not found as of the revision date.

Effects on Lactation and Breastmilk

Relevant published information was not found as of the revision date.

Substance Identification

Substance Name

Sodium Zirconium Cyclosilicate

CAS Registry Number

17141-74-1

Drug Class

  • Cation Exchange Resins
  • Chelating Agents

Disclaimer: Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. The U.S. government does not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.